Used in neuroscience research to model Parkinson’s disease in animals. It is metabolized in the body to an active compound that selectively damages dopaminergic neurons in the substantia nigra, mimicking the neurodegeneration seen in Parkinson’s. This makes it a valuable tool for studying disease mechanisms and testing potential therapeutic drugs. Commonly administered in experimental settings to induce motor deficits and biochemical changes similar to those in human patients. Also used to evaluate the efficacy of neuroprotective agents and novel treatments such as deep brain stimulation or stem cell therapy.